Wedge Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.33M	Buy	73,900 +6,614	+10%	+$208K	0.04%	301
2025 Q1	$2.2M	Buy	67,286 +13,955	+26%	+$457K	0.04%	304
2024 Q4	$1.93M	Buy	+53,331	New	+$1.93M	0.03%	335